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Abstract
 
Leukocyte traffic through secondary lymphoid tissues is finely tuned by chemokines. We have
studied the functional properties of a human T cell subset marked by the expression of CXC
chemokine receptor 5 (CXCR5). Memory but not naive T cells from tonsils are CXCR5
 
1
 
and migrate in response to the B cell–attracting chemokine 1 (BCA-1), which is selectively ex-
pressed by reticular cells and blood vessels within B cell follicles. Tonsillar CXCR5
 
1
 
 T cells do
not respond to other chemokines present in secondary lymphoid tissues, including secondary
lymphoid tissue chemokine (SLC), EBV-induced molecule 1 ligand chemokine (ELC), and
stromal cell–derived factor 1 (SDF-1). The involvement of tonsillar CXCR5
 
1
 
 T cells in hu-
moral immune responses is suggested by their localization in the mantle and light zone germi-
nal centers of B cell follicles and by the concomitant expression of activation and costimulatory
markers, including CD69, HLA-DR, and inducible costimulator (ICOS). Peripheral blood
CXCR5
 
1
 
 T cells also belong to the CD4
 
1
 
 memory T cell subset but, in contrast to tonsillar
cells, are in a resting state and migrate weakly to chemokines. CXCR5
 
1
 
 T cells are very ineffi-
cient in the production of cytokines but potently induce antibody production during coculture
with B cells. These properties portray CXCR5
 
1
 
 T cells as a distinct memory T cell subset with
B cell helper function, designated here as follicular B helper T cells (T
 
FH
 
).
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Introduction
 
T cell–dependent immune responses to pathogens are initi-
ated in specialized lymphoid tissues, including LNs, Peyer’s
patches (PPs),
 
1
 
 and the spleen. The outcome of these de-
fensive mechanisms relies on the finely tuned traffic of T
and B cells as well as antigen-presenting cells, suggesting
that chemokines may be involved in the recruitment and
proper positioning of leukocytes within these compart-
ments. Chemokines comprise a large family of structurally
related chemoattractant proteins that regulate the composi-
tion of cellular infiltrates at sites of inflammation or, alter-
natively, the physiological leukocyte migration during
hematopoiesis, antigen sampling in secondary lymphoid tis-
sues, and immune surveillance (1–6). This report focuses
on a particular subset of T cells with homing selectivity for
B cell follicles in secondary lymphoid tissues.
Chemokines shown to be produced in LNs, PPs, or
the spleen include secondary lymphoid tissue chemokine
(SLC; CCL21) (systematic nomenclature for human che-
mokines available at http://cytokine.medic.kumamoto-
u.ac.jp/), EBV-induced molecule 1 ligand chemokine
(ELC; CCL19), B cell–attracting chemokine 1 (BCA-1;
CXCL14), stromal cell–derived factor 1 (SDF-1; CXCL12),
and monocyte-derived chemokine (MDC; CCL22 [6–8]).
In addition, several typical inflammatory chemokines are
upregulated in inflamed rather than resting LNs, which
may reflect an enhanced T cell activation status. In contrast
to SDF-1 and MDC, the role of SLC and ELC in control-
ling cellular traffic in secondary lymphoid tissues is well es-
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tablished. The two chemokines are produced within T
zone areas but are absent in B cell follicles, and their
expression is dependent on TNF and/or lymphotoxin
(LT)
 
a
 
/
 
b
 
 (4, 6, 7). CC chemokine receptor 7 (CCR7), the
selective receptor for SLC and ELC, is present on the bulk
of resting T cells in peripheral blood and mature dendritic
cells and mediates rapid adhesion to integrin ligands and
chemotactic migration (1–4, 6, 7). Importantly, mutant
mice with defective SLC/ELC production (9–12) and
gene-targeted mice that lack CCR7 (13) show severe de-
fects in secondary lymphoid tissue architecture, notably in
the proper positioning of T and B cells and in the homing
function of mature dendritic cells. Consequently, these
mutant mice display markedly delayed kinetics in T cell–
dependent immune responses whereas antibody responses
remain largely unaffected.
What about the involvement of chemokines in the reg-
ulation of humoral responses? BCA-1 is a highly efficient
chemoattractant for mature B cells that uniformly express
its receptor CXC chemokine receptor 5 (CXCR5 [14–
16]). In mice, the lack of CXCR5 or BLC (the murine
homologue of human BCA-1) resulted in abnormal lym-
phoid tissue formation (17, 18), notably follicular organiza-
tion in the spleen and PPs, whereas transgenic mice
expressing BLC in pancreatic islets showed secondary
lymphoid tissue–like structures at these sites (19), suggest-
ing an important role for BCA-1 in the organization of hu-
man B cell follicles. However, CXCR5 deficiency does
not prevent murine B cell responses, and occasionally small
germinal center–like B cell aggregates are observed (20). In
mice, BCA-1 transcripts are detected in follicles and, simi-
lar to SLC and ELC, its expression is also dependent on
TNF and/or LT
 
a
 
/
 
b
 
 (11, 15, 21, 22). In humans, BCA-1
expression was mainly studied in 
 
Helicobacter pylori
 
–associ-
ated lymphoid tissue and gastric lymphomas (23). In addi-
tion to B cells, low numbers of human peripheral blood T
cells and a larger fraction of tonsillar T cells express
CXCR5 but their function is not known (17, 24). Here
we report the migration and effector properties of human
CXCR5
 
1
 
 T cells present in blood and tonsils. Distinct mi-
gration properties and the ability to induce antibody pro-
duction during coculture with B cells indicate that
CXCR5 expression marks a T cell fraction with unique ef-
fector function.
 
Materials and Methods
 
Antibodies.
 
Antibodies to human proteins were purchased
from the following sources: rat antibodies to IL-5 (TRFK5) and
IL-10 (JES3-9D7), and mouse antibodies to CD4 (RPA-T4),
CD40 (5C3), CD45RO (UCHL1), CD45RA (HI100), CD62L
(DREG-56), CD69 (FN50), CD134 (ACT35), CD152 (BNI3),
and CD154 (TRAP-1) were all from BD PharMingen; mouse
antibodies to CCR6 (53103.111), CXCR3 (49801.111),
CXCR4 (12G5), and goat IgG to BCA-1 (AF470) were from
R&D Systems; mouse antibodies to IFN-
 
g
 
 (25723.11), IL-2
(5344.111), IL-4 (3010.211), and IL-13 (JES10-5A2) were from
Becton Dickinson; mouse antibody to CD71 (DF1513) was from
Sigma-Aldrich; mouse antibodies to CD4 (MT310), CD19
(HD37), CD20 (L26), CD21 (1F8), CD25 (ACT-1), and CD31
(JC/70A), rabbit IgG to CD3 (A0452), and bovine S-100 were
from Dako; mouse antibodies to CCR3 (7B11) and CCR5
(5C7) were from LeukoSite, Inc.; and mouse antibody to HLA-
DR (L243) was from Research Diagnostics Inc. Secondary and
control antibody reagents were from the following sources: goat
anti–rabbit IgG (F-1262), mouse IgG1, and goat IgG were from
Sigma-Aldrich; biotinylated rabbit anti–rat IgG (E0468) and
mouse IgG2a were from Dako; goat anti–mouse MicroBead IgG
(484-01) and goat anti–rabbit MicroBead IgG (486-02) were
from Miltenyi Biotec; mouse IgG2b was from R&D Systems;
rabbit IgG was from Zymed Laboratories; rat IgG was from BD
PharMingen; biotinylated donkey anti–goat/sheep Ig (AB360)
was from The Binding Site. The following antibodies were from
noncommercial sources: rat antibody to CCR7 (3D12; M. Lipp,
Max-Delbrück Center for Molecular Medicine, Berlin, Ger-
many); mouse antibody to inducible costimulator (ICOS; F44;
R.A. Kroczek, Robert Koch Institute, Berlin, Germany); mouse
antibody to CD3 (Tr66; A. Lanzavecchia, Institute for Research
in Biomedicine, Bellinzona, Switzerland); and rabbit IgG to
CXCR5 (23).
 
Cell Preparation and Cultures.
 
Human PBLs were isolated
from donor blood buffy coats by centrifugation on Ficoll-Paque
followed by Percoll (25). For the measurement of intracellular
cytokines, CD4
 
1
 
CD45RO
 
1
 
 PBLs were negatively selected by
removing CD8
 
1
 
, CD14
 
1
 
, CD16
 
1
 
, CD45RA
 
1
 
, and CD56
 
1
 
 cells
using the magnetic cell sorting system from Miltenyi Biotec. The
cells obtained were also used to study the induction of CXCR5
expression after removal of the CXCR5
 
1
 
 cells. Tonsils from in-
dividuals undergoing tonsillectomy were mechanically dispersed
and lymphocytes were isolated by centrifugation on Ficoll-
Paque. CD4
 
1
 
CD45RO
 
1
 
CXCR5
 
1
 
 
 
tonsillar cells were isolated
by first removing CD8
 
1
 
, CD20
 
1
 
, CD45RA
 
1
 
, and CD56
 
1
 
 cells
and then by positive selection of CXCR5
 
1
 
 cells (
 
.
 
97% purity).
Lymphocytes were cultured in RPMI 1640 containing 2 mM
 
L
 
-glutamine, 1% nonessential amino acids, 1% sodium pyruvate,
50 
 
m
 
g/ml penicillin/streptomycin, 5 
 
3
 
 10
 
2
 
5
 
 M 2-mercaptoetha-
nol (GIBCO BRL), and 10% heat-inactivated FCS (Inotech/
Biological Industries). Cells were stimulated with 5 
 
m
 
g/ml anti-
CD3 precoated on tissue plates or 1 
 
m
 
g/ml PHA (Wellcome) in
the presence of 20 U/ml IL-2.
 
T Cell Effector Functions.
 
For detection of intracellular cyto-
kines, purified CD4
 
1
 
CD45RO
 
1
 
 PBLs were stimulated with 10
ng/ml PMA and 1 
 
m
 
g/ml ionomycin for 6 h, and 10 
 
m
 
g/ml
Brefeldin A was added for the last 4 h. Cells were then fixed with
2% paraformaldehyde, permeabilized with 0.2% saponin/2% FCS
in PBS, and stained with the appropriate antibodies to cytokines
for flow cytometric analysis (FACScan™; Becton Dickinson).
Labeling of surface proteins was performed before fixation.
T cell help in antibody production was studied as follows.
Tonsillar T cells (CD4
 
1
 
CXCR5
 
1
 
 and CD4
 
1
 
CXCR5
 
2
 
) and B
cells (CD4
 
2
 
CD8
 
2
 
CXCR5
 
1
 
) were sorted by FACS
 
®
 
 and cocul-
tured in 96-well plates at 10
 
5
 
 cells/well each of T and B cells in
the absence of IL-2 for 10 d. IgM, IgG, and IgA contents in the
culture supernatants were determined by ELISA.
 
T Cell Chemotaxis.
 
Cell migration was measured in 48-well
chemotaxis chambers (Neuro Probe Inc. [25]). In brief, chemo-
kines in Hepes-buffered RPMI 1640 supplemented with 1% pas-
teurized plasma protein (Swiss Red Cross Laboratory) were
added to the lower wells and 100,000 cells in the same medium
to the upper wells. Polyvinylpyrrolidone-free polycarbonate
membranes (Poretics Corp.) with 3-
 
m
 
m pores coated with type
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IV collagen were used. After incubation for 1.5 h, the membrane
was removed, washed on the upper side with PBS, fixed, and
stained. Migrated cells were counted microscopically at 1,000
 
3
 
magnification in five randomly selected fields per well. The assay
was performed in triplicates.
 
Northern Blot Analysis.
 
Total RNA was extracted from
CXCR5
 
1
 
 T cells immediately after isolation or after stimulation
with anti-CD3, and 10-
 
m
 
g samples were analyzed by Northern
blotting using 
 
32
 
P-labeled receptor DNA fragments (10
 
9
 
 cpm/mg
DNA) as hybridization probes (26). The following probes were
used: a 550-bp BamH1 fragment for CXCR4 (27), a 550-bp
BstX1 fragment for CXCR5 (14), and a 430-bp BstX1 fragment
for CCR7 (26).
 
Immunohistochemistry and In Situ Analysis.
 
Tonsillar tissue sec-
tions were either snap frozen in liquid nitrogen or, alternatively,
formaldehyde fixed and paraffin embedded. For immunostaining,
sections of frozen tissue were fixed with acetone, air dried, and
incubated in 10% rabbit or swine serum in Tris-buffered saline
(TBS) containing 0.01% Tween 20, and then further processed as
the paraffin-embedded sections. Optimal staining for S-100,
CD21, CD45RO, and HLA-DR required incubation of paraf-
fin-embedded sections with proteinase (proteinase XXV; Sigma-
Aldrich) for 6 min at 37
 
8
 
C, and identification of CD3
 
1
 
 or
CD20
 
1
 
 cells was improved by three times boiling of paraffin-
embedded sections (microwave, 5 min each time) in 10 mM ci-
trate buffer, pH 6.0, before incubation with primary antibodies in
TBS containing 1% rabbit or swine serum plus either 2% Tween
20 (S-100) or 0.01% Tween 20 (others). After overnight incuba-
tion, sections were treated by standard alkaline phosphatase anti–
alkaline phosphatase (APAAP) or avidin–biotin complex (ABC)
techniques (Dako) for mouse or rabbit/goat antibodies, respec-
tively, stained with New Fuchsin solution (New Fuchsin Kit;
Dako), counterstained with Mayer’s hematoxylin (Fluka), and
mounted using Aquamount (BDH Laboratory Supplies). For
double immunofluorescence staining, frozen sections were incu-
bated with goat anti–BCA-1 antibody and mouse anti-CD31 an-
tibody as described above, then further processed in TBS/0.5%
BSA with biotinylated sheep anti–goat antibody/streptavidin-
Cy5–RPE (C0050; Dako) for BCA-1, followed by FITC-goat
anti–mouse Ig (F0479; Dako) for CD31, and, finally, mounted
with Mowiol (Aventis) plus 0.02% diazabicyclo[2.2.2]octane
(DABCO; Fluka) to avoid bleaching. Stained sections were ana-
lyzed by light or confocal microscopy (Nikon microscope Eclipse
E600 or ZEISS Laser Scanning Microscope LSM410).
For in situ hybridization, digoxigenin (DIG)-labeled RNA
probes of 368 nucleotides corresponding to the 5
 
9
 
 region in the
BCA-1 DNA (14) were prepared by in vitro transcription using
the DIG RNA labeling kit (Roche Diagnostics). Dewaxed/rehy-
drated and proteinase-treated paraffin-embedded sections were
fixed in 4% paraformaldehyde/PBS
 
 
 
and acetylated for 10 min
with 26.4 mM acetic anhydride in 0.1 M triethanolamine. After
prehybridization in 4
 
3
 
 SSC, 50% deionized formamide, 2
 
3
 
Denhardt’s solution, 250 
 
m
 
g/ml yeast RNA, and 100 
 
m
 
g/ml
salmon sperm DNA for 2 h at 50
 
8
 
C, sections were incubated at
50
 
8
 
C overnight with 10 ng of DIG-labeled sense or antisense
RNA probes in 4
 
3
 
 SSC, 1% dextran sulfate, 50% deionized for-
mamide, 2
 
3
 
 Denhardt’s solution, 500 
 
m
 
g/ml yeast RNA, and
500 
 
m
 
g/ml salmon sperm DNA. After one washing with 2
 
3
 
 SSC
at room temperature for 30 min, RNase T1 (Roche Diagnostics)
treatment at 100,000 U/ml, and additional washings at 54
 
8
 
C with
2
 
3
 
 SSC followed by 0.2
 
3
 
 SSC, DIG-labeled RNA was detected
by anti-DIG antibody coupled to alkaline phosphatase and color
development according to the supplier (Roche Diagnostics).
 
Results
 
CXCR5
 
1
 
 T Cells in Blood and Tonsils.
 
Coexpression of
cell surface markers with CXCR5 on human T cells was
analyzed by flow cytometry (Table I). In peripheral blood,
CXCR5 is present on a subpopulation of memory
(CD45RO
 
1
 
) T cells, but absent on naive (CD45RA
 
1
 
) T
cells, as reported previously (17, 24). Over 90% of
CXCR5
 
1
 
 T cells express CD4 and 
 
,
 
10% express CD8.
About 20% of total CD4
 
1
 
CD45RO
 
1
 
 T cells are
CXCR5
 
1
 
, showing that CXCR5 is less frequent on these
cells than on B cells, which uniformly express CXCR5 (16,
17, 24, 28). Circulating CXCR5
 
1
 
 T cells are in a resting
state (CD25
 
2
 
, CD69
 
2
 
, CD71
 
2
 
, HLA-DR
 
2
 
) and lack the
expression of costimulatory molecules (CD40L, OX40,
ICOS), suggesting that they are not involved in ongoing
immune responses. In contrast, CXCR5
 
1
 
 T cells are highly
enriched in inflamed tonsillar tissue. Almost all memory T
cells (
 
.
 
95%) are CD4
 
1
 
 and stain positive for CXCR5,
whereas naive T cells do not express CXCR5. Further-
more, several activation markers (CD69, HLA-DR, ICOS)
are found on the majority of CXCR5
 
1
 
 T cells, suggesting
that this fraction is engaged in tonsillar immune responses
(Table I). Other inducible T cell markers, including alter-
native costimulatory molecules (CD40L, OX40, CTLA-4)
or activation/proliferation markers (CD25, CD71), were
not detected.
 
Modulation of CXCR5 Expression and Migration to BCA-1.
 
The migration capacity of leukocytes and, consequently,
their potential involvement in immune responses, depends
largely on the repertoire of chemokine receptors that are
functionally expressed. CCR7, which defines homing of
circulating T cells to T cell compartments within secondary
 
Table I.
 
Phenotypic Markers on CXCR5
 
1
 
 T Cells in Blood
and Tonsils
 
Marker Blood Tonsils
CD4 95 
 
6
 
 2.1 (8)
 
*
 
92 
 
6
 
 4.3 (7)
CD8 5 
 
6
 
 1.5 (8) 8 
 
6
 
 2.9 (7)
CD45RO 98 
 
6 1.9 (8) 97 6 2.5 (7)
CD25 1 6 0.5 (5) 1 6 0.8 (5)
CD69 3 6 0.8 (5) 88 6 4.1 (5)
CD71 1 6 0.5 (5) 2 6 1.2 (5)
HLA-DR 2 6 0.9 (5) 78 6 9.8 (5)
OX40 (CD134) 1 6 0.6 (4) 3 6 1.4 (4)
CD40L (CD154) 2 6 1.9 (4) 2 6 1.4 (4)
CTLA-4 (CD152) 1 6 0.6 (4) 2 6 0.8 (4)
ICOS 4 6 1.2 (5) 65 6 8.5 (5)
CD62L 82 6 4.8 (5) 42 6 5.8 (5)
Freshly isolated CXCR51CD31 T cells from blood or tonsils were
analyzed by three-color flow cytometry.
*Percentage 6 SEM of CXCR51CD31 T cells expressing the indi-
cated cell surface proteins (gates set at 99% control antibody staining);
numbers in parentheses refer to independent cell preparations analyzed.
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lymphoid tissues (29–31), is coexpressed on virtually all cir-
culating CXCR51 T cells (Table II). This is in striking
contrast to the marked reduction of CCR7 expression on
tonsillar CXCR51 T cells (Fig. 1), suggesting that SLC and
ELC, the ligands of CCR7, may have caused its down-
modulation (2). Similarly, L-selectin (CD62L) expression is
reduced on tonsillar CXCR51 T cells compared with
blood CXCR51 T cells, implying that the majority of ton-
sillar CXCR51 T cells have recently immigrated from cir-
culation. No striking differences between blood and tonsil-
lar CXCR51 T cells were observed for other chemokine
receptors. CXCR4 is unique in its uniform but weak ex-
pression on freshly isolated blood and tonsillar T cells (see
below). Fractions of similar size stain positive for CXCR3,
CCR3, CCR5, and CCR6, whereas other chemokine re-
ceptors were not detected.
Freshly isolated tonsillar CXCR51 T cells migrated
readily in response to BCA-1, whereas responsiveness to
ELC and SDF-1 was routinely low or undetectable (Fig. 2
a). Responsiveness to BCA-1 was moderately enhanced
when the cells were treated with anti-CD3 or PHA (not
shown). Prolonged activation resulted in complete loss of
chemotaxis and receptor expression, and this effect corre-
lates with the appearance of T cell blasts (Fig. 2, a and b).
CXCR5 transcripts were readily detected in freshly isolated
CXCR51 T cells and decreased to undetectable levels by
day 6 of culture (Fig. 2 d). These observations are in strik-
ing contrast to changes in ELC- and SDF-1–mediated re-
sponses and in the expression of their receptors. Initially,
chemotaxis to ELC and SDF-1 remained low until respon-
siveness to BCA-1 started to decline, i.e., T cell blast and
cell proliferation became evident, and then rapidly in-
creased to levels exceeding the maximal responses observed
with BCA-1 (Fig. 2 a). CCR7 protein and mRNA expres-
sion increased during the first 3 d of activation, followed by
a slow decline. Of note, these changes do not correlate
with changes in T cell migration, as marked responses were
observed only in the phase of chemokine receptor down-
modulation (Fig. 2, a and b). CXCR4 is uniformly but at
low levels present on freshly isolated tonsillar CXCR51 T
cells and high level expression is restored by overnight cul-
ture under nonstimulatory conditions (Fig. 2 c), suggesting
receptor relocation from intracellular stores rather than de
novo gene expression (32–34). In this respect, CXCR4 ex-
pression clearly differs from the expression of CXCR5 and
CCR7, which was not affected by overnight culture (Fig. 2
c). However, similar to ELC/CCR7, enhancement of
chemotaxis to SDF-1 occurred late in culture and was not
related to changes in cell surface CXCR4.
Peripheral blood CXCR51 T cells migrated poorly to
BCA-1 (25 6 5 migrated cells/5 high power fields [HPFs];
n 5 3). Similar to tonsillar CXCR51 T cells, activation
with anti-CD3 or PHA led to a transient enhancement of
migration, reaching maximal levels by day 3 (92 6 6 mi-
grated cells/5 HPFs; n 5 3), followed by a rapid decline in
both BCA-1–mediated migration and CXCR5 expression.
CXCR5 expression in naive T cells was not achieved by
common stimulation protocols (anti-CD3 with or without
anti-CD28) and, thus, may require accessory stimulation
provided by antigen-presenting cells. Loss of CXCR5 ex-
pression and responsiveness to BCA-1 was routinely ob-
served during in vitro culture of T cells, as evidenced by 10
independent cell lines established from sorted CXCR51 T
cells from blood or tonsils. Also, CXCR5 expression was
completely absent in numerous unrelated T cell lines with
defined antigen specificity and cytokine production profile.
Cytokine Profile of CXCR51 T Cells. The pattern of
cytokine production was studied by flow cytometry in
Table II. Chemokine Receptor Profile on CXCR51CD41 T 
Cells in Blood and Tonsils
Receptor Blood Tonsils
CXCR3 25 6 3.2 (5)* 30 6 4.3 (5)
CXCR4‡ 34 6 15 (5) 29 6 12 (5)
CCR3 3 6 2.9 (3) 9 6 5.0 (3)
CCR5 4 6 3.2 (3) 14 6 9.4 (3)
CCR6 32 6 5.5 (4) 36 6 6.8 (4)
CCR7 97 6 2.5 (5) 28 6 6.2 (5)
Freshly isolated CXCR51CD41 T cells from blood or tonsils were
analyzed by three-color flow cytometry for coexpression of chemokine
receptors.
*Percentage 6 SEM of CXCR51CD41 T cells expressing the indi-
cated chemokine receptors (gates set at 99% control antibody staining);
numbers in parentheses refer to independent cell preparations analyzed.
‡All blood and tonsillar T cells express high levels of CXCR4 after
overnight culture under nonstimulatory conditions (see also Fig. 2 c).
Figure 1. CCR7 and CD62L are downmodulated on tonsillar
CXCR51 T lymphocytes. Freshly isolated blood and tonsillar lympho-
cytes were triple stained with antibodies to CD4, CXCR5, and CCR7 or
CD62L and analyzed by flow cytometry. Dot plots show cells gated for
the expression of CD4. Quadrants were set according to the staining of
control antibodies and the percentage of cells in each quadrant is indi-
cated. Comparable results were obtained with five additional blood and
tonsillar cell preparations.
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CXCR51 and CXCR52 peripheral blood T cells after po-
tent polyclonal stimulation (35). Only minor populations
within CXCR51 T cells were capable of producing IFN-g
(11.2 6 1.5%; mean 6 SEM); IL-4, IL-5, IL-10, and IL-13
were not produced (,3%; Fig. 3 a). As expected, both
CXCR51 and CXCR52 T cells synthesized IL-2 equally
well (77.2 6 1.0 and 80.0 6 1.1%, mean 6 SEM, respec-
tively). In contrast, CXCR52 T cells produced more
prominently IFN-g (28.4 6 0.6%, mean 6 SEM), IL-4
(12.0 6 1.5%, mean 6 SEM), and IL-13 (13.5 6 2.6%,
mean 6 SEM; Fig. 3 a). Of note, the loss of CXCR5 ex-
pression in long-term cultures was accompanied by the ac-
quisition of enhanced cytokine production, as shown in
cell lines generated from sorted CXCR51 T cells. Except
for IL-2 and IFN-g, CXCR51 T cells from tonsils did not
produce cytokines, which fully agrees with the results ob-
tained with blood CXCR51 T cells.
B Cell Helper Function of CXCR51 T Cells. Coculture
experiments with tonsillar T and B cells showed that
CXCR51 T cells are potent inducers of antibody produc-
tion (Fig. 3 b). CXCR51 T cells enhanced the production
of IgG and IgA by a factor of 6.3 6 2.1 (mean 6 SEM,
n 5 4) and 4.6 6 1.7 (mean 6 SEM, n 5 4), respectively,
compared with CXCR52 T cells. Both T cell fractions
were equally potent in induction of IgM secretion (1.3 6
0.6–fold [mean 6 SEM, n 5 4] enhancement by CXCR51
T cells), and IgM levels were consistently lower than those
of IgG, suggesting that CXCR51 T cells affected B cell Ig
switching (IgM to IgG/IgA) and/or memory B cell activa-
tion. B cells cultured in the absence of T cells produced
marginal levels of antibodies (,60 ng/ml for IgG and IgM,
and ,30 ng/ml for IgA). In contrast to tonsillar T cells,
CXCR51 T cells from peripheral blood did not support
antibody production in B cell cultures in the absence of ex-
ogenous stimuli, which correlates with their resting state.
Colocalization of CXCR51 T Cells and BCA-1 Production
in Tonsils. Prominent attraction by BCA-1 and reduced
responsiveness to SLC, ELC, and SDF-1 suggest that ton-
sillar CXCR51 T cells are recruited to sites of BCA-1 pro-
duction. Immunohistochemistry and in situ hybridization
of tonsillar tissue sections revealed the highly selective ex-
Figure 2. Inhibition of migration to BCA-1 and CXCR5 expression
during culture of tonsillar CXCR51 T cells. Freshly isolated tonsillar
CXCR51 T cells were activated with immobilized anti-CD3 for up to
6 d and examined for in vitro migration (a); chemokine receptor expres-
sion was assessed by flow cytometry (b and c) and Northern blot analysis
(d). (a) Chemotaxis in response to 1,000 nM BCA-1 (d), 100 nM SDF-1
(u), and 100 nM ELC (,; mean number of migrated cells per 5 HPFs in
triplicate wells). The data are representative of five independent experi-
ments. (b) The percentage of cells positive for CXCR5 (d), CXCR4
(u), and CCR7 (,), with gates set at 99% isotype-matched control anti-
body staining. (c) Expression of CXCR5, CXCR4, and CCR7 (shaded)
in freshly isolated cells and in cells treated with anti-CD3 for 3 d. Broken
lines represent the staining of isotype-matched control antibodies, and
solid lines show chemokine receptor expression after overnight culture
under nonstimulatory conditions. (d) Northern blot analysis of CXCR5,
CXCR4, and CCR7 transcripts with total RNA from freshly isolated
cells and after treatment with anti-CD3 for 3 and 6 d.
Figure 3. Lack of cytokine production but induction of IgG/IgA syn-
thesis by CXCR51 T cells. (a) CD41CD45RO1 T cells were isolated
from blood by negative selection. After polyclonal stimulation, CXCR51
and CXCR52 CD41 T cells were examined for intracellular production
of IFN-g, IL-2, IL-4, IL-5, IL-10, and IL-13 by three-color flow cytom-
etry. Dot plots show cells gated for CD4. Quadrants were set according
to the staining of isotype-matched control antibodies and the percentage
of cells in each quadrant is indicated. Results are representative of a total
of 11 experiments with memory T cell preparations from different blood
and tonsil donors. (b) CXCR51 T cells induce antibody production in
tonsillar B cells. Tonsillar B cells were cultured for 10 d either alone (B)
or in the presence of CXCR51 (X51/B) or CXCR52 T cells (X52/B),
and IgG, IgA, and IgM concentrations in the culture supernatants were
determined by ELISA. A representative example out of four independent
experiments is shown.
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pression of BCA-1 in the follicular mantle zone and, albeit
less prominently, in the light zone of germinal centers (Fig.
4, a and b), which markedly contrasts with the T zone–
selective expression of SLC and ELC (4, 6, 7). Positivity in
the mantle zone is associated with reticular cells, as demon-
strated by the intense staining of dendrite-like cellular ex-
tensions (Fig. 4 c, inset). BCA-1–producing cells may rep-
resent a distinct class of dendritic cells, as their localization
differs from follicular (CD211) or interdigitating (S-1001)
dendritic cells (Fig. 4, e and f). In addition, prominent
BCA-1 production is found on high endothelial venules
(HEVs) within follicles but not in the T zone, as shown by
single staining (Fig. 4 c, arrowheads). This is supported by
confocal microscopy with fluorescence-labeled antibodies
to BCA-1 (red) and CD31 (green), demonstrating colocal-
ization in follicular HEVs (yellow) (Fig. 4 d; inset shows T
zone HEVs). In 20 randomly selected areas in tonsillar sec-
tions (0.32 mm2/each), a total of 699 vessels were identi-
Figure 4. BCA-1 expression in tonsillar follicles. (a and c) Immunostaining of BCA-1 (red) in frozen tonsillar sections; inset in panel a shows control
staining with isotype-matched control. (b) In situ hybridization of BCA-1 transcripts using an antisense probe (black) on paraffin sections; no staining is
observed with a sense probe (inset in b). Positivity in the mantle zone is associated with reticular cells, as highlighted in the inset of c, and follicular HEVs
(white arrowheads in c) but not T zone HEVs (black arrowheads in c). (d) Confocal microscopic analysis of BCA-1 (red) and CD31 (green) expression
in follicular HEVs and T zone HEVs (inset in d). Immunostaining of interdigitating dendritic cells with an anti–S-100 antibody (e) and follicular dendritic
cells with an anti-CD21 antibody (f) is shown to highlight the nonoverlapping localization of BCA-1–producing reticular cells. Original magnifications:
(a, e, and f) 3100; (b and c) 3200; and (d) 31,600.
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fied by anti-CD31 staining and 99 out of 101 BCA-11 ves-
sels were located in the follicular mantle. This selectivity
in vascular BCA-1 expression suggests that circulating
CXCR51 cells could be directly recruited into B cell folli-
cles via BCA-1–induced attachment to follicular HEVs.
Numerous CD31 T cells are present in the light zone of
germinal centers, and similar high numbers of cells at this
location stained positive for CD4 (not shown), HLA-DR,
CD69, or ICOS (Fig. 5). These data agree with the follicu-
lar localization of tonsillar CXCR51 T cells, which express
these activation markers (Table I). Follicular T cells are
greatly outnumbered by B cells, which all express CXCR5
(not shown [16, 17, 24, 28]). Follicular mantle zones are
areas of intensive cellular interactions, and dense nuclear
staining with eosin/hematoxylin greatly diminishes over-
lapping signals obtained by immunohistochemistry. Never-
theless, positive staining for CD3, CD4, CD45RO, HLA-
DR, CD69, and ICOS was clearly detected and, as
expected, was much less prominent than staining for CD20
(B cells).
Discussion
Recruitment of lymphocytes into secondary lymphoid
tissue requires the presence of CD62L, which mediates ini-
tial adhesive interactions of lymphocytes on HEVs (36),
and CCR7, which triggers subsequent firm adhesion
through integrin activation (30, 31, 37–39). This mecha-
nism is operative for naive T cells, whose numbers are dras-
tically reduced in secondary lymphoid tissues of CCR7- or
Figure 5. Phenotypic characterization of follicular T cells. Immunostaining (red) on paraffin sections is shown for CD3 (a), CD20 (b), CD45RO (c),
and HLA-DR (e), and on frozen sections for CD69 (d) and ICOS (f). Original magnification: 3100.
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SLC-deficient mice (10, 13), and may also apply to mem-
ory T cells, which give rise to effector cells during recogni-
tion of recall antigens. The majority (65–95%; n 5 5) of
resting/memory T cells in peripheral blood are double pos-
itive for CD62L and CCR7, and termed central memory T
cells (TCM) to designate antigen-experienced T cells with
secondary lymphoid tissue–homing characteristics (29).
CXCR5 is present on a subset of circulating CD41 mem-
ory T cells with poor cytokine production capabilities that
coexpress CD62L and CCR7. CXCR5 expression is negli-
gible (3%) on CD81 T cells and is absent on naive T cells.
Accordingly, peripheral CXCR51 T cells represent a sub-
population of TCM and, thus, differ from CCR72 effector
memory T cells (TEM), which are proposed to directly par-
ticipate in immune responses at inflammatory sites (29).
In addition to CCR7, CXCR51 T cells uniformly ex-
press low levels of CXCR4, but there is no evidence for a
role of this receptor in T cell traffic through secondary
lymphoid tissues. Except for CXCR3, CXCR51 T cells
lack chemokine receptors that are typically involved in re-
cruitment of effector/memory T cells to inflammatory sites
in peripheral tissues. This chemokine receptor profile sug-
gests that CXCR51 T cells home preferentially into sec-
ondary lymphoid tissues and, therefore, T cells from tonsils
were selected for further studies. Tonsils of patients with
pharyngeal inflammation contain a high density of second-
ary follicles separated by small T zone areas, indicative of
intensive B cell activation processes. Therefore, CXCR51
T cells within this tissue may actively participate in local
immune responses. Practically all (.95%) CD41 memory
T cells in tonsils are CXCR51 and the majority express ac-
tivation markers (CD69, HLA-DR, ICOS) suggesting their
engagement in B cell activation. Drastic reduction in cell
surface CCR7 and CD62L indicates that the majority of
local CXCR51 T cells have recently entered the tonsillar
tissue (see below).
Tonsillar CXCR51 T cells readily migrate in response to
BCA-1, demonstrating that CXCR5 is functional. How-
ever, CXCR5 expression and responsiveness to BCA-1 are
sensitive to T cell activation, as shown by polyclonal stimu-
lation of tonsillar and circulating CXCR51 T cells. This
contrasts strikingly with the migration responses to ELC
and SDF-1, which are only observed late in CXCR51
T cell culture, well after enhancement of CCR7 and
CXCR4 expression, illustrating that these two chemokine
systems are not essential for the localization of CXCR51 T
cells within tonsils. Failure in finding CXCR52 T cell lines
and the inability to induce reexpression of this receptor in
cell lines derived from sorted CXCR51 and CXCR52 T
cells led us to propose that CXCR5 marks nonproliferating
memory T cells. Consequently, CXCR51 T cells in pe-
ripheral blood may represent a subset of memory T cells
that have left secondary lymphoid tissues before clonal ex-
pansion. The requirements for induction of CXCR5 ex-
pression in naive T cells are not defined. Preliminary data
indicate that PHA or anti-CD3/CD28 stimulation are not
sufficient, suggesting that CXCR5 expression in naive T
cells requires contact with antigen-presenting cells. In sup-
port, CXCR5 expression during primary responses in mice
was shown to depend on sequential signaling by CD28 and
OX40 (40, 41).
How are circulating CXCR51 T cells recruited into
tonsillar follicles? BCA-1 production is highly concentrated
in the mantle zone, but is also found in the light zone of
germinal centers, marking B cell areas with prominent T
cell involvement. In agreement, follicular T cells colocalize
with BCA-1–producing cells and express the same range of
subset (CD4, CD45RO) and activation markers (CD69,
HLA-DR, ICOS) that are present on CXCR51 T cells
freshly isolated from tonsils. Evidently, CXCR5 expression
characterizes the subset of tonsillar T cells that are attracted
to areas with prominent BCA-1 production. Cellular
sources of BCA-1 include reticular cells in the follicular
mantle and follicular HEVs. Selective expression of BCA-1
in follicular as opposed to T zone HEVs may represent an
important address code for direct recruitment of circulating
CXCR51 T cells into B cell follicles. Similarly, SLC is se-
lectively expressed on T zone (but not follicular) HEVs and
is shown to direct the transmigration of CCR7-bearing T
cells through induction of firm adhesion and subsequent
diapedesis (30, 31, 38, 42). As such, BCA-1 and SLC are
nonoverlapping in their sorting function and may therefore
contribute to an efficient positioning of T cells with mutu-
ally exclusive properties within secondary lymphoid tissues.
Peripheral blood B cells differ from the bulk of T cells in
their uniform expression of both CXCR5 and CCR7.
B cell recruitment into secondary lymphoid tissues of
CXCR5- or CCR7-deficient mice is not impaired, sug-
gesting that the absence of either chemokine receptor can
be compensated by signaling through the other chemokine
receptor (6, 13, 17, 30, 43). However, CXCR5 (but not
CCR7) is critical for B cell follicle formation in the spleen
and PPs (13, 17), which fits well with the follicular local-
ization of CXCR51 T cells.
CXCR51 memory T cells are poor producers of cyto-
kines. However, expression of ICOS strongly suggests that
tonsillar CXCR51 T cells are engaged in B cell activation.
This CD28-related costimulatory molecule is induced dur-
ing T cells activation and is prominently expressed on T
cells in the mantle and light zone of secondary follicles (44;
and shown here). The B7-related ICOS ligand is expressed
on B cells and macrophages and costimulates, together with
TCR signaling, T cell proliferation (45–47). Hyperplasia in
secondary lymphoid tissues, plasmacytosis, and elevated
levels of blood IgG in transgenic mice that constitutively
express soluble ICOS ligand point to a prominent role of
this costimulatory system in proliferative and B helper re-
sponses of follicular T cells (46). A functional link between
ICOS and CXCR5 expression is suggested here by the se-
lective production of IgG and IgA during coculture of ton-
sillar CXCR51 T cells with B cells. Due to the preactiva-
tion status of tonsillar T cells, exogenous stimuli were not
required for B cell stimulation, and lack of preferential IgM
synthesis suggests that CXCR51 T cells are mainly active
during secondary antibody responses. These effector func-
tions together with the follicular localization demonstrate
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that CXCR51 T cells play an important regulatory role in
humoral immunity and led us to propose the term follicular
B helper T cells (TFH) to designate this particular T cell
subset.
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